These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Endothelial differentiation potential of human monocyte-derived multipotential cells. Kuwana M; Okazaki Y; Kodama H; Satoh T; Kawakami Y; Ikeda Y Stem Cells; 2006 Dec; 24(12):2733-43. PubMed ID: 16888284 [TBL] [Abstract][Full Text] [Related]
5. Platelet-derived stromal cell-derived factor-1 is required for the transformation of circulating monocytes into multipotential cells. Seta N; Okazaki Y; Miyazaki H; Kato T; Kuwana M PLoS One; 2013; 8(9):e74246. PubMed ID: 24066125 [TBL] [Abstract][Full Text] [Related]
6. [Advances in the research of peripheral blood mononuclear cell-derived multipotential cell]. Xie Y; Chen B; Wang H; Wang K; Li R Zhonghua Shao Shang Za Zhi; 2016 Dec; 32(12):762-764. PubMed ID: 28043301 [TBL] [Abstract][Full Text] [Related]
7. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. Kuwana M; Okazaki Y; Kodama H; Izumi K; Yasuoka H; Ogawa Y; Kawakami Y; Ikeda Y J Leukoc Biol; 2003 Nov; 74(5):833-45. PubMed ID: 12960274 [TBL] [Abstract][Full Text] [Related]
8. Fibronectin binding is required for acquisition of mesenchymal/endothelial differentiation potential in human circulating monocytes. Seta N; Okazaki Y; Izumi K; Miyazaki H; Kato T; Kuwana M Clin Dev Immunol; 2012; 2012():820827. PubMed ID: 23251222 [TBL] [Abstract][Full Text] [Related]
9. Human circulating monocytes can express receptor activator of nuclear factor-kappaB ligand and differentiate into functional osteoclasts without exogenous stimulation. Seta N; Okazaki Y; Kuwana M Immunol Cell Biol; 2008 Jul; 86(5):453-9. PubMed ID: 18301383 [TBL] [Abstract][Full Text] [Related]
10. A novel population of mesenchymal progenitors with hematopoietic potential originated from CD14 peripheral blood mononuclear cells. Hu G; Liu P; Feng J; Jin Y Int J Med Sci; 2010 Dec; 8(1):16-29. PubMed ID: 21209798 [TBL] [Abstract][Full Text] [Related]
17. Anti-L-NGFR and -CD34 monoclonal antibodies identify multipotent mesenchymal stem cells in human adipose tissue. Quirici N; Scavullo C; de Girolamo L; Lopa S; Arrigoni E; Deliliers GL; Brini AT Stem Cells Dev; 2010 Jun; 19(6):915-25. PubMed ID: 19929314 [TBL] [Abstract][Full Text] [Related]
18. Functional and phenotypic analysis of thymic CD34+CD1a- progenitor-derived dendritic cells: predominance of CD1a+ differentiation pathway. Dalloul AH; Patry C; Salamero J; Canque B; Grassi F; Schmitt C J Immunol; 1999 May; 162(10):5821-8. PubMed ID: 10229816 [TBL] [Abstract][Full Text] [Related]
19. Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro. Alviano F; Fossati V; Marchionni C; Arpinati M; Bonsi L; Franchina M; Lanzoni G; Cantoni S; Cavallini C; Bianchi F; Tazzari PL; Pasquinelli G; Foroni L; Ventura C; Grossi A; Bagnara GP BMC Dev Biol; 2007 Feb; 7():11. PubMed ID: 17313666 [TBL] [Abstract][Full Text] [Related]
20. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Romagnani P; Annunziato F; Liotta F; Lazzeri E; Mazzinghi B; Frosali F; Cosmi L; Maggi L; Lasagni L; Scheffold A; Kruger M; Dimmeler S; Marra F; Gensini G; Maggi E; Romagnani S Circ Res; 2005 Aug; 97(4):314-22. PubMed ID: 16020753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]